+467.0%
MRNA vs VIK
+34.6%
+432.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VIK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.2% | +4.2% | +5.9% |
| 7D | -1.1% | -0.9% | -0.2% | -1.5% |
| 30D | +126.1% | -18.4% | +144.5% | +121.9% |
| 3M | +190.0% | -8.8% | +198.8% | +171.1% |
| 6M | +157.2% | +17.1% | +140.1% | +112.2% |
| YTD | +388.2% | +19.0% | +369.2% | +291.8% |
| 1Y | +467.0% | +30.1% | +436.9% | +349.6% |
| All | +467.0% | +34.6% | +432.5% | +349.6% |
Cumulative growth
Daily Returns
Daily percentage return beside VIK.
Daily Out/Under-Performance
Portfolio return minus VIK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VIK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VIK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling